Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
137.9 USD | -1.52% |
|
-7.19% | +38.66% |
06-14 | FDA asks COVID vaccine makers to target KP.2 strain with updated shots | RE |
06-13 | Moderna: successful trial for new Covid vaccine | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.66% | 52.85B | |
-7.81% | 38.87B | |
+35.48% | 38.24B | |
-10.77% | 26.79B | |
+11.77% | 26.16B | |
-17.82% | 19.9B | |
+35.09% | 13.18B | |
+29.17% | 12.24B | |
-3.05% | 11.79B | |
-11.84% | 10.74B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna's RSV Vaccine Has 'Ample Opportunity' Despite Seasoned Competitors, Oppenheimer Says